Tetanus cost-effectiveness of therapy: Difference between revisions
m (Changes made per Mahshid's request) |
(Category) |
||
Line 31: | Line 31: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Emergency mdicine]] | |||
[[Category:Disease]] | |||
[[Category:Primary care]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Infectious disease]] | |||
[[Category:Neurology]] |
Revision as of 02:54, 22 September 2017
Tetanus Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Tetanus cost-effectiveness of therapy On the Web |
American Roentgen Ray Society Images of Tetanus cost-effectiveness of therapy |
Risk calculators and risk factors for Tetanus cost-effectiveness of therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Michael Maddaleni, B.S.
Overview
The major cost encountered with tetanus is in the form of the vaccine. There are many different trade names associated with the tetanus vaccine that come with slightly different costs. The prices of the vaccines are all listed in the following tables. The tables are separated based upon pediatric doses versus adult doses. The DTaP vaccine that is mentioned in the passage stands for Diptheria, Tetanus, and Pertussis.